CRNX is no longer listed. Its last trade on record was Sep 2, 2026. The price and figures on this page are from its last trading day and final filings, and are no longer updated.
Ranked by reported Q2 2026 13F market value
Share of total reported institutional value in CRNX held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 15.8M | $592.7M | +0.5% | 14.948% | 0.03% |
| 2 | BlackRock, Inc. | 9.8M | $365.2M | +15.1% | 9.209% | 0.01% |
| 3 | FARALLON CAPITAL MANAGEMENT, L.L.C. | 9.0M | $336.4M | +7.8% | 8.483% | 1.55% |
| 4 | WELLINGTON MANAGEMENT GROUP LLP | 7.1M | $266.8M | -12.6% | 6.729% | 0.05% |
| 5 | DRIEHAUS CAPITAL MANAGEMENT LLC | 6.5M | $241.9M | +1.1% | 6.099% | 1.40% |
| 6 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.8M | $180.8M | +4.2% | 4.560% | 0.01% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 4.7M | $177.6M | +1.5% | 4.478% | 0.00% |
| 8 | Jupiter Topco LLC | 4.6M | $170.5M | — | 4.301% | 0.07% |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 2.7M | $102.1M | +10.0% | 2.574% | 0.01% |
| 10 | STATE STREET CORP | 2.7M | $100.6M | +11.9% | 2.538% | 0.00% |
| 11 | Bellevue Group AG | 2.6M | $98.0M | -20.1% | 2.472% | 2.06% |
| 12 | BAKER BROS. ADVISORS LP | 2.4M | $88.0M | 0.0% | 2.219% | 0.44% |
| 13 | Polar Capital Holdings Plc | 2.3M | $85.1M | — | 2.146% | 0.20% |
| 14 | Pictet Asset Management Holding SA | 2.1M | $77.6M | +10.1% | 1.959% | 0.07% |
| 15 | BNP Paribas Asset Management Holding S.A. | 1.7M | $62.8M | -2.2% | 1.584% | 0.06% |
| 16 | Siren, L.L.C. | 1.4M | $53.2M | -25.4% | 1.341% | 1.08% |
| 17 | First Light Asset Management, LLC | 1.4M | $50.9M | +24.9% | 1.284% | 3.10% |
| 18 | JPMORGAN CHASE & CO | 1.4M | $50.6M | +3.0% | 1.288% | 0.00% |
| 19 | MORGAN STANLEY | 1.3M | $50.1M | +45.5% | 1.263% | 0.00% |
| 20 | BANK OF AMERICA CORP /DE/ | 1.3M | $49.9M | +86.2% | 1.258% | 0.00% |
| 21 | Novo Holdings A/S | 1.3M | $49.4M | -14.8% | 1.246% | 2.87% |
| 22 | DIMENSIONAL FUND ADVISORS LP | 1.3M | $47.5M | +49.1% | 1.199% | 0.01% |
| 23 | AMERICAN CENTURY COMPANIES INC | 1.3M | $47.2M | +19.9% | 1.192% | 0.02% |
| 24 | ADAR1 Capital Management, LLC | 1.2M | $45.7M | +7.3% | 1.153% | 2.09% |
| 25 | MONTANOVA CAPITAL, LLC | 1.2M | $44.4M | +13.6% | 1.119% | 0.81% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in CRNX — a direct measure of their conviction.
Filings activity in CRNX during Q2 2026, grouped by how each filer changed its position.
Institutions that opened a new CRNX position in Q2 2026
Institutions that fully closed their CRNX position in Q2 2026
8 quarters of 13F filings · Δ columns show change vs prior quarter
| Quarter | Inst. Holders | Δ Holders | Ownership % | Δ Ownership | Total 13F Value | Δ Value |
|---|---|---|---|---|---|---|
| Q2 2026 | 268 | +8.9% | 116.79% | +0.26 pp | $4.25B | +2.9% |
| Q1 2026 | 246 | +0.4% | 116.53% | 1.17 pp | $4.13B | 15% |
| Q4 2025 | 245 | +11% | 117.70% | +2.68 pp | $4.86B | +15% |
| Q3 2025 | 220 | 0.5% | 115.02% | +4.05 pp | $4.23B | +53% |
| Q2 2025 | 221 | +0.0% | 110.97% | +2.37 pp | $2.76B | 12% |
| Q1 2025 | 221 | 9.1% | 108.60% | +1.69 pp | $3.14B | 32% |
| Q4 2024 | 243 | +6.6% | 106.91% | +3.19 pp | $4.60B | +20% |
| Q3 2024 | 228 | — | 103.72% | — | $3.84B | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying CRNX stock.
Based on Q2 2026 13F filings, institutional ownership of Crinetics Pharmaceuticals, Inc. stands at 116.8%, held across 268 reporting institutions.
FMR LLC is the largest reported institutional holder of CRNX, with approximately 15,840,219 shares worth $0.59B as of Q2 2026.
No marquee "smart money" managers (Berkshire, Burry, ARK, Tiger Global, Pershing Square, Baupost, etc.) currently appear among the top 25 institutional holders of CRNX.
Our composite Smart Money Score for CRNX is 47 out of 100 (Neutral). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
52 institutions opened new positions in CRNX during Q2 2026, while 31 fully exited. 150 added to existing positions and 58 trimmed.
CRNX institutional ownership rose by 0.26 percentage points quarter-over-quarter, with a net change of +22 holders.
The top 10 institutions account for 59.6% of all reported 13F value in CRNX, and the top 25 account for 80.8%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Crinetics Pharmaceuticals, Inc. (CRNX) Institutional Ownership